Innoviva Newsroom

Innoviva Analyst Ratings

BenzingaAug 2 01:10

Innoviva Analyst Ratings

BenzingaJul 30 22:20

Innoviva Analyst Ratings

BenzingaJun 18 20:12

Analysts Offer Insights on Healthcare Companies: Lonza Group Ltd (Six Swiss: CH:LONN), Harrow Health (HROW) and Innoviva (INVA)

TipRanksApr 3 17:05

Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Innoviva (INVA) and Arcutis Biotherapeutics (ARQT)

TipRanksMay 10, 2023 20:40

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaMay 10, 2023 19:57

Analysts Offer Insights on Healthcare Companies: BioCryst (BCRX), Innoviva (INVA) and Pliant Therapeutics (PLRX)

TipRanksApr 21, 2023 00:42

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaApr 20, 2023 20:45

What 4 Analyst Ratings Have To Say About Innoviva

BenzingaMar 4, 2023 05:05

Morgan Stanley Sticks to Their Sell Rating for Innoviva (INVA)

TipRanksMar 4, 2023 00:31

Goldman Sachs Remains a Hold on Innoviva (INVA)

TipRanksMar 4, 2023 00:31

Morgan Stanley Adjusts Price Target on Innoviva to $10 From $13, Maintains Underweight Rating

MT NewswiresMar 3, 2023 23:43

Morgan Stanley Maintains Underweight on Innoviva, Lowers Price Target to $10

BenzingaMar 3, 2023 22:40

EF Hutton Reiterates Buy on Innoviva, Maintains $22.5 Price Target

BenzingaMar 3, 2023 22:20

Morgan Stanley Sticks to Its Sell Rating for Innoviva (INVA)

TipRanksJan 25, 2023 00:40

Innoviva Analyst Ratings

Benzinga Analyst RatingsJan 24, 2023 21:56